Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254161 (CHEMBL461011 | N-(5-tert-butylisoxazol-3-yl)-2-(4-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254147 (CHEMBL467029 | N-(3-tert-butyl-1-methyl-1H-pyrazol...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | n/a | n/a | 25 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254144 (2-(4-chlorophenylsulfonyl)-2-methyl-N-(5-(5-methyl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254143 (CHEMBL511404 | N-(4-chloro-3-(furan-2-yl)phenyl)-2...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254104 (CHEMBL466603 | N-(4-chloro-3-(trifluoromethyl)phen...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254067 (2-methyl-N-(quinolin-3-yl)-2-(4-(trifluoromethyl)p...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254102 (2-(4-chlorophenylsulfonyl)-2-methyl-N-(3-(trifluor...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 35 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254101 (2-(4-chlorophenylsulfonyl)-2-methyl-N-(quinolin-3-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254100 (2-(4-fluorophenylsulfonyl)-2-methyl-N-(quinolin-3-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254068 (2-(2-chloro-4-(trifluoromethyl)phenylsulfonyl)-2-m...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 73 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50254103 (2-(4-chlorophenylsulfonyl)-2-methyl-N-(4-(trifluor...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 57 | n/a | n/a | n/a | n/a |
Amgen Inc Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as suppression of forskolin-stimulated cAMP accumulation | Bioorg Med Chem Lett 19: 31-5 (2008) Article DOI: 10.1016/j.bmcl.2008.11.026 BindingDB Entry DOI: 10.7270/Q2FF3S7X | |||||||||||
More data for this Ligand-Target Pair |